Living Cell Technologies Limited
LVCLY · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $11 | $14 | $4 | $7 |
| - Cash | $3 | $4 | $4 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $8 | $10 | -$0 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 1,134% | -98.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 98.7% | 78.2% | 81.6% |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | – | -3,015.6% | -42,848.3% | -498.3% |
| Net Income | -$2 | -$2 | -$2 | -$1 |
| % Margin | – | -5,016.3% | -57,483.1% | -544.6% |
| EPS Diluted | -0.013 | -0.016 | -0.022 | -0.024 |
| % Growth | 18.8% | 27.3% | 8.3% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$1 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$1 |